PRODUCT DETAILS (International)

FiberNet® EP System Design

Clinical Experience

The FiberNet system has been evaluated in over 200 patients worldwide. Enrolling trials include the recently initiated EPIC Pivotal Trial in the U.S. and EPIC Europe for the carotid artery indication, and the RETREIVE feasibility study for the saphenous vein graft indication.

CE 0123 Marking

Contact Us Today

For more information on the FiberNet system and participation in ongoing or future investigational trials, contact us today.

June 28, 2011

Medtronic purchases the FiberNet Embolic Protection product line from Lumen Biomedical Inc

February 8, 2010

Volcano announces purchase of Xtract Product

Learn More

January 12, 2010

Completion of FORTRESS clinical study

Learn More

May 18, 2009

Volcano Announces Worldwide Exclusive Distribution Agreement With Lumen Biomedical for Xtract(TM) Thrombus Aspiration Catheter

Learn More

January 29, 2009

Invatec Announces Worldwide Distribution Agreement with Lumen Biomedical

Learn More

November 19, 2008

FDA Approves Lumen Biomedical's FiberNet Embolic Protection System for Carotid Artery Stenting

Learn More

October 22, 2008

Lumen Biomedical Receives FDA Clearance of Embolectomy System for Treatment of Peripheral Artery Disease

Learn More


Past Press Releases